Soluble FcγRIIIb (CD16b) and Alpha Defensin as Markers of Neutrophils Activation in Periodontal Disease

Fatima Sabah  Jasim; Batool Hassan  Al-Ghurabi

doi:10.30526/38.3.3660

Authors

Fatima Sabah Jasim Department of Basic Science, College of Dentistry, University of Baghdad. Baghdad, Iraq. https://orcid.org/0009-0004-5788-2072
Batool Hassan Al-Ghurabi Department of Basic Science, College of Dentistry, University of Baghdad. Baghdad, Iraq. https://orcid.org/0000-0001-9775-4906

DOI:

https://doi.org/10.30526/38.3.3660

Keywords:

periodontitis disease, neutrophils, cluster of differentiation 16b and alpha defensin

Abstract

Neutrophils in saliva cause tissue death in inflammatory disorders, including periodontal disease. Identifying biomarkers for neutrophil mediators is crucial for accurate diagnosis in periodontics research. This study is to investigate the salivary levels of soluble cluster of differentiation 16b (sCD16b) and alpha defensin, which are biomarkers of neutrophil activation in patients with periodontal diseases, and to examine the correlation between these levels and clinical periodontal parameters. In this particular case-control study, a total of sixty subjects who were diagnosed with periodontal disease, including 30 with periodontitis and 30 with gingivitis, were recruited. These subjects ranged in age from 17 to 65 years. The study also included 25 healthy volunteers, matching their ages and genders with those of the patients. The periodontal parameters utilized in this study included plaque index, bleeding on probing, probing pocket depth, and clinical attachment loss. We collected saliva samples from all participants, including both patients and controls. In order to estimate the salivary levels of sCD16b and alpha defensin, ELISA was performed. The present findings revealed a significant increase (P≤0.05) in the salivary levels of sCD16b and alpha defensin in periodontitis and gingivitis patients as compared to the control group. Moreover, there was a significant increase (P≤0.05) in the level of sCD16b among periodontitis patients when compared to gingivitis patients, while for the alpha-defensin level, there was no significant difference (P>0.05) between the two groups. On the other hand, this study found a significantly positive correlation for two biomarkers with CAL in the periodontics group. This study indicated that an increase in salivary levels of sCD16b and alpha defensin could be associated with enhanced innate response in periodontics disease, and might serve as biomarkers of neutrophil activation in periodontal disease

Author Biographies

Fatima Sabah Jasim, Department of Basic Science, College of Dentistry, University of Baghdad. Baghdad, Iraq.

Department of Basic Science, College of Dentistry, University of Baghdad. Baghdad, Iraq.
Batool Hassan Al-Ghurabi, Department of Basic Science, College of Dentistry, University of Baghdad. Baghdad, Iraq.

Department of Basic Science, College of Dentistry, University of Baghdad. Baghdad, Iraq.

References

1. Otenio C, Fonseca I, Martins M, Ribeiro L, Assis N, Ferreira A, Ribeiro R. Expression of IL-1, IL-6, TNF-α, and iNOS in pregnant women with periodontics disease. Genet Mol Res. 2012;11:4468–78. https://doi.org/10.4238/2012.September.20.3

2. Fatima H, Mouruj AS. Screening of periodontics disease related Bacteria in Iraqi patients and their relationship with salivary TLR2 and IL-6 level. Iraqi J Sci. 2023;64(7):4240–8. doi:10.24996/ijs.2023.64.7.15.

3. Herrero ER, Fernandes S, Verspecht T, Ugarte-Berzal E, Boon N, Proost P, Teughels W. Dysbiotic biofilms deregulate the periodontics inflammatory response. J Dent Res. 2018;97(5):547–55. https://doi.org/10.24996/ijs.2023.64.7.15

4. Van Dyke TE. Pro-resolving mediators in the regulation of periodontics disease. Mol Aspects Med. 2017;58:21–36. https://doi.org/10.1016/j.mam.2017.04.006

5. Rudick CP, Lang MS, Miyamoto T. Understanding the pathophysiology behind chairside diagnostics and genetic testing for IL-1 and IL-6. Oral Dis. 2019;25(8):1879–85. https://doi.org/10.1111/odi.13030

6. Kumaresan D, Balasundaram A, Naik VK, Appukuttan DP. Gingival crevicular fluid periostin levels in chronic periodontics patients following nonsurgical periodontics treatment with low-level laser therapy. Eur J Dent. 2016;10(4):546–50. https://doi.org/10.4103/1305-7456.195179

7. Aljubouri EA, Alaubydi MA, Alsaadi YD. Salivary immune parameters as a predictor of oral diseases. Iraqi J Sci. 2023;64(6):2741–9. https://doi.org/10.24996/ijs.2023.64.6.8

8. Al-Obaidi MJ, Al-Ghurabi BH. Potential role of NLRP3 inflammasome activation in the pathogenesis of periodontics patients with type 2 diabetes mellitus. J Med Chem Sci. 2023;6(3):522–31.

9. Al-Ghurabei BH, Shaker ZF, Fadhel R, Al-Khayli NG, Mustafa LK. Serum levels of interleukin-1β and interleukin-2 in chronic periodontics. Al-Mustansiriya J Sci. 2012;23(3):55–62.

10. Shaker ZF, Hashem BH. Study the role of proinflammatory and anti-inflammatory cytokines in Iraqi chronic periodontics patients. J Bagh Col Dent. 2012;24(1):164–9.

11. Al-Ghurabi BH, Mohssen SM. Salivary level of RANKL and OPG in chronic periodontics. J Bagh Col Dent. 2015;27(1):189–94.

12. Özdemir B, Özmeric N, Elgün S, Barış E. Smoking and gingivitis: Focus on inducible nitric oxide synthase, nitric oxide and basic fibroblast growth factor. J Periodont Res. 2015;51:596–603. https://doi.org/10.1111/jre.12338

13. Franco C, Patricia HR, Timo S, Claudia B, Marcela H. Matrix metalloproteinases as regulators of periodontics inflammation. Int J Mol Sci. 2017;18(2):440. https://doi.org/10.3390/ijms18020440

14. Gul SS, Abdulkareem AA, Sha AM, Rawlinson A. Diagnostic accuracy of oral fluids biomarker profile to determine the current and future status of periodontics and peri-implant diseases. Diagnostics. 2020;10(10):838. https://doi.org/10.3390/diagnostics10100838

15. Heidari Z. The association between proinflammatory gene polymorphisms and level of gingival tissue degradation in chronic periodontics disease. Gene Cell Tissue. 2014;1:e21898. https://doi.org/10.17795/gct-21898

16. Heidari Z, Moudi B, Mahmoudzadeh-Sagheb H. Immunomodulatory factors gene polymorphisms in chronic periodontics disease: An overview. BMC Oral Health. 2019;19:29. https://doi.org/10.1186/s12903-019-0715-7.

17. Al Kubaisi MW, Al Ghurabi BH. Evaluation of Manuka honey effects on dental plaque and bacterial load (clinical study). J Med Chem Sci. 2023;6(2):365–375. https://doi.org/10.26655/JMCHEMSCI.2023.2.17

18. Miles K, Clarke DJ, Lu W, Sibinska Z, Beaumont PE, Davidson DJ, Barr TA, Campopiano DJ, Gray M. Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins. J Immunol. 2009;183(3):2122–2132. https://doi.org/10.4049/jimmunol.0804187

19. Ashby M, Petkova A, Hilpert K. Cationic antimicrobial peptides as potential new therapeutic agents in neonates and children: a review. Curr Opin Infect Dis. 2014;27:258–267.

20. Khurshid Z, Naseem M, Sheikh Z, Hassan F. Oral antimicrobial peptides: types and role in the oral cavity. Saudi Pharm J. 2016;24:515–524.

21. Hirschfeld J. Neutrophil subsets in periodontics health and disease: a mini review. Front Immunol. 2020;10:3001. https://doi.org/10.3389/fimmu.2019.03001

22. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Erlbaum; 1988.

23. Chapple ILC, Mealey BL, Van Dyke TE, Bartold PM, Dommisch H, Eickholz P, Geisinger ML, Genco RJ, Glogauer M, Goldstein M, Griffin TJ, Holmstrup P, Johnson GK, Kapila Y, Lang NP, Meyle J, Murakami S, Plemons J, Romito GA, Shapira L, Tatakis DN, Teughels W, Trombelli L, Walter C, Wimmer G, Xenoudi P, Yoshie H. Periodontics health and gingival diseases and conditions on an intact and a reduced periodontium. J Clin Periodontol. 2018;45(Suppl 20):S68–S77. https://doi.org/10.1111/jcpe.12940

24. Tenovuo J, Lagerlöf F. In: Thylstrup A, Fejerskov O, editors. Textbook of Clinical Cariology. 2nd ed. Copenhagen: Munksgaard; 1994. p. 17–43.

25. Huizinga TW, de Haas M, Kleijer M, Nuijens JH, Roos D, von dem Borne AEGK. Soluble Fc gamma receptor III in human plasma originates from release by neutrophils. J Clin Invest. 1990;86(2):416–423. https://doi.org/10.1172/JCI114727

26. Lakschevitz FS, Hassanpour S, Rubin A, Solis R, Kushner M, Anders M.Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200–209.

27. Nagasawa T, Kobayashi H, Aramaki M. Expression of CD14, CD16 and CD45RA on monocytes from periodontic patients. J Periodont Res. 2004;39(1):72–8. https://doi.org/10.1111/j.1600-0765.2004.00713.x

28. Reeves EP, Bergin DA, Fitzgerald S. A novel neutrophil derived inflammatory biomarker of pulmonary exacerbation in cystic fibrosis. J Cyst Fibros. 2012;11(2):100–7. https://doi.org/10.1016/j.jcf.2011.09.010

29. Medara N, Lenzo JC, Walsh KA. Peripheral neutrophil phenotypes during management of periodontics. J Periodont Res. 2021;56(1):58–68. https://doi.org/10.1111/jre.12793

30. Abiko Y, Nishimura M, Kaku T. Defensins in saliva and the salivary glands. Med Electron Microsc. 2003;36(4):247–52. https://doi.org/10.1007/s00795-003-0225-0

31. Agerberth B, Charo J, Werr J. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood. 2000;96(9):3086–93.

32. Gamonal J, Acevedo A, Bascones A. Characterization of cellular infiltrate, detection of CCR5 and chemokines in adult periodontics. J Periodont Res. 2001;36(3):194–203. https://doi.org/10.1034/j.1600-0765.2001.360309.x

33. Lundy FT, Orr DF, Shaw C. Detection of human neutrophil peptides 1–3 in gingival crevicular fluid by MALDI-MS. Mol Immunol. 2005;42(5):575–9. https://doi.org/10.1016/j.molimm.2004.09.008

34. Puklo M, Guentsch A, Hiemstra PS. Analysis of antimicrobial peptides in gingival crevicular fluid suggests role of LL-37. Oral Microbiol Immunol. 2008;23(4):328–35. https://doi.org/10.1111/j.1399-302X.2008.00433.x

35. Mulli TK. Proteomic investigation of salivary biomarkers in periodontics diseases. MSc thesis; 2012.

36. McKay MS, Olson E, Hesla MA, Panyutich A, Ganz T, Perkins S, Rossomando EF. Immunomagnetic recovery of human neutrophil defensins from gingival crevice. Oral Microbiol Immunol. 1999;14(3):190–193.

37. Al-Ghurabi BH, Adham ZS, Abbas AA. Level of β-defensin among Iraqi patients with COVID-19 in relation to oral health status. J Emerg Med Trauma Acute Care. 2022;2022(3):2. https://doi.org/10.5339/jemtac.2022.ismc.2.

38. Türkoğlu O, Emingil G, Kütükçüler N, Atilla G. Evaluation of gingival crevicular fluid adrenomedullin and HNP 1–3 levels in different periodontics diseases. J Periodontol. 2010;81(2):284–291. https://doi.org/10.1902/jop.2009.090517.

39. Al-Daragi FZ, Al-Ghurabi BH, Abdullah NN. Serum levels of antimicrobial peptides (Cathelicidins and Beta Defensins 1) in patients with periodontitis. J Bagh Col Dent. 2024;36(1):9–18. https://doi.org/10.26477/jbcd.v36i1.3586.